Short answer
Nutex Health Inc. (NUTX) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $218M (down 18.7% year over year) with net income of $40M.
Q3 2026 key financials · XBRL
- Revenue
- $218M
- −18.7% YoY · +3.3% QoQ
- Net income
- $40M
- −27.4% YoY · −38.9% QoQ
- Operating margin
- 35.4%
- Gross margin
- 46.7%
- EPS (diluted)
- $5.63
- −32.3% YoY · −39.8% QoQ
Source: XBRL data from the Nutex Health Inc. (NUTX) Q3 2026 10-Q on SEC EDGAR. USD.
Nutex Health Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $217.6M, down $50.2M YoY from $267.8M, driven by hospital revenue decline
- Operating margin 35.4% vs 48.7% YoY, net income margin 26.4% vs 36.1%
- Best segment: population health revenue $8.5M vs $7.6M; worst: hospital revenue $209.1M vs $260.2M
- Cash $249.9M vs $185.6M at December 31, 2025; operating cash flow $188.1M
- Headwinds: IDR volatility, regulatory changes, cybersecurity incident, uncertain enforcement of unpaid awards
Risk Factors
- Cybersecurity incident: August 2026 unauthorized access and exfiltration of patient, employee, provider, business and financial data
- Legal exposure: putative class actions filed in Southern District of Texas over alleged inadequate security measures
- Regulatory compliance: HIPAA, Texas privacy laws, Senate Bill 1188 and SEC cybersecurity rules create evolving obligations
- Operational risk: third-party technology failures could disrupt systems and expose sensitive information
- Financial risk: remediation costs and liabilities may exceed insurance coverage
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Nutex Health Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.